Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M, Sidoti A, Albani D, Massat I, Höfer P, Amital D, Juven-Wetzler A, Kasper S, Zohar J, Souery D, Montgomery S, Mendlewicz J.
Calati R, et al.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:271-8. doi: 10.1016/j.pnpbp.2013.03.005. Epub 2013 Mar 26.
Prog Neuropsychopharmacol Biol Psychiatry. 2013.
PMID: 23537502